Wall Street Zen downgrades Intuitive Surgical stock to Hold

Published on 10/02/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock costs EUR 359.10 versus EUR 358.30 on October 2, 2026. Revenue hit USD 2.89 billion in second quarter 2026, up 18.40 percent.

Pop-Art-Comic zeigt Operationsroboter mit mehreren Armen und Chirurgen an der Konsole — Farbenfrohe Pop-Art-Comic-Szene aus dem Operationssaal illustriert Intuitive Surgical Inc. (US46120E6023) mit dynamischer Chirurgie-Roboter-Darstellung, Illustration mit AI erstellt.

Intuitive Surgical (ISIN US46120E6023) traded at EUR 359.10 at Lang & Schwarz on October 2, 2026 at 1:30 p.m. CEST, while Wall Street Zen downgraded the company to Hold from Buy on September 20, 2026, according to MarketBeat. The rating change puts valuation and procedure growth at the center of the stock debate.

Analyst split sharpens the debate

MarketBeat reports that 22 analysts rate Intuitive Surgical a Buy, eight assign Hold ratings and one assigns a Sell rating. The resulting Moderate Buy consensus carries an average USD 508.68 price target, while the report also cites BTIG Research maintaining a Buy rating and a USD 469.00 target on September 8, 2026.

The contrast is material. Wall Street Zen moved from Buy to Hold, yet the broader analyst count remains tilted toward positive ratings, leaving the USD 508.68 consensus target as a key valuation reference rather than a company forecast.

Second-quarter growth remains measurable

Intuitive Surgical generated USD 2.89 billion of revenue in the second quarter of 2026, an 18.40 percent increase from the same quarter a year earlier, according to Yahoo Finance. Net income reached USD 818.10 million, while the GAAP earnings per share figure was USD 2.80 against a USD 2.48 consensus estimate.

The company is expanding beyond the da Vinci surgical system through the Ion endoluminal system, which supports minimally invasive lung biopsies. Its operating profile therefore combines recurring instruments and services with new system placements, making procedure volume and hospital spending important markers for the next report.

October results set the next test

Yahoo Finance lists October 20, 2026 as Intuitive Surgical's next earnings date. The report will give investors a fresh comparison with second-quarter revenue of USD 2.89 billion and net income of USD 818.10 million, while the analyst consensus will be measured against the Hold signal from Wall Street Zen.

At Lang & Schwarz, Intuitive Surgical was trading at EUR 359.10 on October 2, 2026 at 1:30 p.m. CEST, plus 0.22 percent versus the prior close of EUR 358.30. The primary Nasdaq listing closed at USD 401.24 on October 1, 2026, while the 52-week range was USD 328.57 to USD 603.88 and market capitalization stood at USD 141.7 billion as of October 1, 2026. The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.